TAK

Takeda Pharmaceutical Company Limited

Sağlık

NON-COMPLIANT — One or more ratios exceed the threshold; the company is not compliant with halal investment criteria.

$18.77

Price (1 Year)

Participation Finance Screening Ratios

Non-compliant debt / Total market cap %65.6 / %30

Non-compliant assets / Total market cap %2.3 / %30

Non-compliant income / Total income %5.4 / %5

Ratios are taken from an AAOIFI-based screening file; this does not constitute a religious ruling.

About the Company

Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma-derived therapies, oncology, vaccines, and neuroscience.